DNAM-1-chimeric receptor-engineered NK cells, combined with Nutlin-3a, more effectively fight neuroblastoma cells in vitro: a proof-of-concept study.

Authors
Publication date
28 July 2022
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    ART

    redirect
    oaioai:art.torvergata.it:2108/305...
    Last time updated on 30/10/2022